A tool to help collect biomarkers remotely in clinical trials for substance use disorders.
MyTrials: An Integrated Tool to Support Remote Biomarker Capture within Decentralized Clinical Trials for Substance Use Disorders
This study is testing a new tool called MyTrials that helps researchers collect important health samples from people with substance use disorders more easily and from home, making it simpler for everyone involved and hopefully leading to better treatment options for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mountainpass Technology, LLC NIH-funded |
| Lab location | 1 site (Chevy Chase, United States) |
| Project ID | NIH-11053714 on NIH RePORTER |
What this research studies
This research focuses on developing an integrated tool called MyTrials, which aims to facilitate the remote collection of biomarkers in decentralized clinical trials for individuals with substance use disorders. The tool addresses the challenges of existing biomarker capture methods that are primarily designed for clinical use rather than research. By enabling the simultaneous collection of multiple biospecimens, MyTrials seeks to streamline the process for researchers and improve the feasibility of conducting trials across various institutions. Patients will benefit from a more efficient trial process that can lead to better treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are participating in clinical trials for substance use disorders.
Not a fit: Patients who are not involved in clinical trials or do not have substance use disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and streamlined clinical trials for substance use disorders, ultimately improving treatment outcomes for patients.
How similar studies have performed: Other research has shown promise in developing remote biomarker capture methods, but this integrated approach is relatively novel and aims to address specific challenges in substance use disorder trials.
Where this research is happening
Chevy Chase, United States
- Mountainpass Technology, LLC — Chevy Chase, United States (Active)
Researchers
- Principal investigator: Dahne, Jennifer Renee — Mountainpass Technology, LLC
- Study coordinator: Dahne, Jennifer Renee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.